Latest News for: gsk

Edit

Current Report by Foreign Issuer (Form 6-K) (GSK plc)

Public Technologies 24 Feb 2026
GSK plc published this content on February 24, 2026, and is solely responsible ...
Edit

Frontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics

The Facts 24 Feb 2026
... agreement with GSK, a global biopharma company.
Edit

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract

Business Wire 24 Feb 2026
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract ... .
Edit

Transaction notification (Form 6-K) (GSK plc)

Public Technologies 24 Feb 2026
GSK plc ... GSK plc (the 'Company') ... GSK plc ... Acquisition of notional ADS within Dr Barron's GSK Executive Supplemental Savings Plan account following the reinvestment of dividends ... GSK plc ... About GSK ... Find out more at www.gsk.com ... GSK plc ... behalf of GSK plc.
Edit

Tender Offer Statement (Form SC TO-T/A) (GSK plc)

Public Technologies 24 Feb 2026
GSK PLC ... GSK PLC ... GSK plc published this content on February 24, 2026, and is solely responsible for the information contained herein.
Edit

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract (Bora Pharmaceuticals Co Ltd)

Public Technologies 23 Feb 2026
). The text version of this document is not available ... Disclaimer ... Ltd ... (noodl.
Edit

Survey finds majority of older Canadians with chronic illnesses unaware of increased shingles risk (GSK - GlaxoSmithKline Inc)

Public Technologies 23 Feb 2026
Michelle Horn, Country Medical Director, GSK Canada, commented ... The national survey was conducted by Human8, on behalf of GSK ... About GSK ... Find out more at gsk.ca ... 2008;26;675-697 Human8 on behalf of GSK ... Human8 on behalf of GSK ... Human8 on behalf of GSK.
Edit

GSK plc (the 'Company') Transaction notification (Form 6-K) (GSK plc)

Public Technologies 20 Feb 2026
GSK plc ... GSK plc (the 'Company') ... GSK plc ... About GSK. GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com ... GSK plc ... behalf of GSK plc.
Edit

See what the epic GSK share price recovery has done to £10,000 in the last year

The Motley Fool 18 Feb 2026
GSK) share price was bumping along around a 10-year low ... As key treatments went off patent, GSK struggled to replenish revenues with new blockbusters ... So is it time to show GSK some love again? ... Should you invest £1,000 in GSK right now?.
Edit

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM (GSK plc)

Public Technologies 18 Feb 2026
GSK plc (LSE/NYSE. GSK) announced that ... ViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE. GSK) and Pfizer (NYSE ... About GSK ... Find out more at https.//www.gsk.com.
Edit

GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe ...

The Joplin Globe 18 Feb 2026
PHILADELPHIA--(BUSINESS WIRE)--Feb 18, 2026-- ... .
Edit

GSK plc announces the fourth tranche of share buyback programme (Form 6-K) (GSK plc)

Public Technologies 17 Feb 2026
GSK plc ... On 24 February 2025, GSK plc ("GSK") announced the commencement of a £2 billion share buyback programme (the "Programme"), as announced in its 2024 full year results announcement published on 5 February 2025 ... About GSK.
Edit

JAX-NYSCF Collaborative and GSK Announce Collaboration to Advance Translational Models for Neurodegenerative Disease Research

PR Newswire 17 Feb 2026
17, 2026 /PRNewswire/ -- The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) today announced a five-year strategic research collaboration with GSK focused on advancing ...
Edit

Awards under the Deferred Investment Award Programme (Form 6-K) (GSK plc)

Public Technologies 17 Feb 2026
GSK plc ... GSK plc (the 'Company') ... GSK plc ... GSK plc ... About GSK. GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com ... GSK plc ... behalf of GSK plc.
Edit

£1,000 buys 11,500 shares in this red hot healthcare penny stock that’s smashing GSK

The Motley Fool 17 Feb 2026
GSK shares are doing really well at the moment ... An exciting health stock ... HVO) ... The post £1,000 buys 11,500 shares in this red hot healthcare penny stock that’s smashing GSK appeared first on The Motley Fool UK ... The Motley Fool UK has recommended GSK.

Article Search

tools
×
×
×
×